causal
Concentrated portfolio sized to exclude binary risk
Impactive holds eight to 12 positions, each 8% to 12% of AUM at cost, and because of this concentration it excludes binary-outcome businesses such as biotech and pharma where an FDA decision can move the stock tenfold or to zero.
causalpending
Speaker
Lauren Taylor WolfeEvidence Quote
“An example would be biotech or pharmaceuticals where an FDA approval can send the stock up 10X or send it down to zero.”
Created: 11/20/2026, 9:13:21 AM
Your notes
Loading notes...